<DOC>
	<DOCNO>NCT01444235</DOCNO>
	<brief_summary>Comparison cardioprotective effect safety two cardioplegic solution ( solution use cardiac arrest heart surgery ) patient undergo cardiopulmonary bypass coronary artery bypass surgery .</brief_summary>
	<brief_title>Phase III Study Comparing Two Methods Cardioplegia Coronary Artery Bypass Surgery</brief_title>
	<detailed_description>The objective investigation compare cardioprotective effect safety two cardioplegic solution , HTK Cardioplegic Solution ( Custodiol ) Custodiol-N patient undergo cardiopulmonary bypass coronary artery bypass surgery . The study design prospective , double blind , multicenter , randomize , Phase III comparison study intend demonstrate non-inferiority surgical outcome Custodiol Custodiol-N determine CK-MB area curve ( primary endpoint ) , catecholamine requirement ( cumulative dose ) cardiac Troponin T , occurrence comorbid event postoperatively ( e.g. , myocardial infarction ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>The study population select patient either sex coronary artery disease ( CAD ) undergo cardiopulmonary bypass coronary artery bypass surgery . 1 . Patients &gt; /=35 &lt; /=80 year age 2 . Male female 2 3 vessel coronary disease , schedule elective CBP surgery coronary revascularisation 3 . Presence definite CAD surgical intervention deem necessary , without evidence ongoing infarction . Patients unstable angina include long objective ( negative cardiac isoenzymes immediate six hour precede CABG , current intravenous use nitrate therapy ) subjective ( absence prolong symptom suggestive coronary insufficiency respond pharmacologic intervention ) evidence myocardial necrosis . 4 . Eligibility SwanGanzCatheter 5 . Able understand character individual consequence clinical trial provide write informed consent participate study 6 . No evidence severe organic psychiatric disease history physical examination 7 . No history alcohol abuse , illicit drug use , significant mental illness , physical dependence opioid , history drug abuse addiction within 12 month study enrollment . 1 . Patients undergo valve repair replacement 2 . History recent ( &lt; 6 week ) Qwave myocardial infarction 3 . Left ventricular ejection fraction &lt; 35 % ( assessed one following : contrast ventriculography , multigated acquisition scan [ MUGA ] , 2D ECHO ) 4 . Patients intraaortic balloon device history previous coronary artery bypass surgery 5 . Pregnant lactate patient 6 . Patients participate investigational study within 30 day previous enrollment 7 . Patients cardiogenic shock ( define systolic BP &lt; 90 mmHg one hour despite inotropic chronotropic support ) 8 . Patients severe chronic obstructive lung disease ( FEV1 &lt; 50 % ) 9 . Previous cardiac valvular disease ( clinical relevant ) 10 . Dialysis creatinine &gt; 2 mmol/L 11 . BMSStent &lt; 4 week 12 . DESStent &lt; 6 month 13 . Guidance depend Plavix therapy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>CAD , ACVB</keyword>
</DOC>